Paying users zone. Data is covered by 
.
Get 1 month access to Becton, Dickinson & Co. for $17.99, or
get full access to entire website for at least 3 months from $49.99.
We accept:
Becton, Dickinson & Co. (BDX)
Enterprise Value to EBITDA (EV/EBITDA)
Difficulty: Intermediate
Earnings before Interest, Tax, Depreciation and Amortization (EBITDA)
Becton, Dickinson & Co., EBITDA calculation
USD $ in millions
Based on: 10-K (filing date: 2018-11-21), 10-K (filing date: 2017-11-22), 10-K (filing date: 2016-11-23), 10-K (filing date: 2015-11-25), 10-K (filing date: 2014-11-26), 10-K (filing date: 2013-11-27).
| Item | Description | The company |
|---|---|---|
| EBITDA | To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital. | Becton, Dickinson & Co.’s EBITDA increased from 2016 to 2017 and from 2017 to 2018. |
Enterprise Value to EBITDA Ratio, Current
Becton, Dickinson & Co., current EV/EBITDA calculation, comparison to benchmarks
| Selected Financial Data (USD $ in millions) | |
| Enterprise value (EV) | |
| Earnings before interest, tax, depreciation and amortization (EBITDA) | |
| Ratio | |
| EV/EBITDA | |
| Benchmarks | |
| EV/EBITDA, Competitors1 | |
| Intuitive Surgical Inc. | |
| Medtronic PLC | |
| Stryker Corp. | |
| Thermo Fisher Scientific Inc. | |
| UnitedHealth Group Inc. | |
| EV/EBITDA, Sector | |
| Health Care Equipment & Services | |
| EV/EBITDA, Industry | |
| Health Care | |
Based on: 10-K (filing date: 2018-11-21).
1 Click competitor name to see calculations.
If company EV/EBITDA is lower then the EV/EBITDA of benchmark then company is relatively undervalued.
Otherwise, if company EV/EBITDA is higher then the EV/EBITDA of benchmark then company is relatively overvalued.
Enterprise Value to EBITDA Ratio, Historical
Becton, Dickinson & Co., historical EV/EBITDA calculation, comparison to benchmarks
| Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 | Sep 30, 2015 | Sep 30, 2014 | Sep 30, 2013 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (USD $ in millions) | |||||||
| Enterprise value (EV)1 | |
|
|
|
|
|
|
| Earnings before interest, tax, depreciation and amortization (EBITDA)2 | |
|
|
|
|
|
|
| Ratio | |||||||
| EV/EBITDA3 | |
|
|
|
|
|
|
| Benchmarks | |||||||
| EV/EBITDA, Competitors4 | |||||||
| Intuitive Surgical Inc. | |
|
|
|
|
|
|
| Medtronic PLC | |
|
|
|
|
|
|
| Stryker Corp. | |
|
|
|
|
|
|
| Thermo Fisher Scientific Inc. | |
|
|
|
|
|
|
| UnitedHealth Group Inc. | |
|
|
|
|
|
|
| EV/EBITDA, Sector | |||||||
| Health Care Equipment & Services | |
|
|
|
|
|
|
| EV/EBITDA, Industry | |||||||
| Health Care | |
|
|
|
|
|
|
Based on: 10-K (filing date: 2018-11-21), 10-K (filing date: 2017-11-22), 10-K (filing date: 2016-11-23), 10-K (filing date: 2015-11-25), 10-K (filing date: 2014-11-26), 10-K (filing date: 2013-11-27).
3 2018 Calculation
EV/EBITDA = EV ÷ EBITDA
= ÷ =
4 Click competitor name to see calculations.
| Ratio | Description | The company |
|---|---|---|
| EV/EBITDA | EV/EBITDA is a valuation indicator for the overall company rather than common stock. | Becton, Dickinson & Co.’s EV/EBITDA ratio increased from 2016 to 2017 and from 2017 to 2018. |